As the volume and depth of genomic data grows, bioinformaticians are translating genomic data into interpretable patterns leading to new biological insight.
The full benefit of using AI-tools to make predictions and take alternative actions can’t be realised without careful consideration of the accompanying ethical pitfalls, say researchers.
As of yesterday, Rob Brainin, Executive Vice President and Chief Operating Officer, has been appointed as the company’s new Chief Executive Officer.
How can researchers determine the best path forward when so many studies are coming out, each with new information?
A USD $5 million technology prize aims to crack the origin of the genetic code. The Evolution 2.0 Prize was announced at Arizona State University in August 2017. The largest “origin of life” prize to date, it seeks to bridge the gap between chemistry, genomics and modern computing.
Genome Canada has announced plans to provide 3 Canadian Centres of Excellence with $19.6M (£11.1M) of funding over the next five years.
The technology used by Facebook, Google and Amazon to turn spoken language into text, recognize faces and target advertising could help doctors combat one of the deadliest killers in American hospitals.
What’s blockchain technology, how, and why was it developed, and why is everyone talking about it? Alex Schmid provides us with an overview of challenges blockchain technology can help solve within life sciences, and what about it, that makes it so suitable.
As the promise of liquid biopsies continues to impress, startups have already begun selling cheap cancer screening. But, still in its early stages, are they rushing it?
The U.S. are the closest they’ve ever been to using gene-editing tool, CRISPR for the first time in a human test in a bid to tackle deadly cancers.
At ASHG, we spoke to Gavin Stone, Vice President of Marketing at Edico Genome, to discuss their World Record achievement in more detail, as well as the advantages offered by their DRAGEN tool.
Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth.
Despite reports proving the stock market moving up at the at the start of the year, the U.S. equities market seems to be far more mixed, with healthcare stocks looking particularly volatile.
Year 2020 has been set as the delivery date for 500,000 whole exome sequences from the UK Biobank cohorts.
With the Festival of Genomics London just around the corner, we thought it was the right time to turn our attention to the key themes being presented.
What is it that biopharma companies, research institutions, and healthcare facilities all have in common?
Their interest in genomic data.
